A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Tuesday, 17 April 2012

Analysis of SPCs affected by Medeva

GenericsWeb recently undertook an analysis of all SPCs where the subject is a combination (with an expiry date after 01/01/2012), checking the underlying patents to see whether they protected all components of the combination specifically. They came up with some surprising results. The findings were presented at the European Generics Association legal affairs forum earlier this year, and are available in an article published in Generics Bulletin (here). You can also get a copy of the slides presented at the meeting by writing to y.bretonnet@genericsweb.com

Many thanks to Leighton Howard (GenericsWeb) for letting us know!

No comments: